uniQure N.V. - Ordinary Shares — 재무제표 (NASDAQ:QURE)

Financials

총자산 340.39 M809.18 M704.96 M831.69 M556.54 M824.91 M 총 부채 96.49 M213.4 M228.96 M624.02 M563.29 M626.01 M 자본금 총액 243.91 M595.78 M476.01 M207.67 M-6.75 M198.9 M 총 부채 및 주주자본 340.39 M809.18 M704.96 M831.69 M556.54 M824.91 M 총부채 35.62 M100.96 M102.79 M101.75 M51.32 M49.7 M 순부채 35.62 M100.96 M102.79 M101.75 M51.32 M-573.15 M

uniQure N.V. - Ordinary Shares

uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies.

QURE

Financials

uniQure N.V. - Ordinary Shares

뉴스

Biotech Investors Are Tuning Out the MAHA Chaos

uniQure (QURE) Reports Q1 Loss, Misses Revenue Estimates

Kyverna Therapeutics: 'Strong Buy' On Additional POC Of Miv-Cel In Myasthenia Gravis

Nurix Therapeutics (NRIX) Moves 6.9% Higher: Will This Strength Last?

uniQure Investors Sue Company Over Huntington’s Disease Drug Study Claims - TipRanks.com

Biotechs Breathe Easy As Vinay Prasad Plans His Exit. But Should They?

PGIM Jennison Health Sciences Fund Q4 2025 Key Contributors And Detractors

A Unique Situation For UniQure (QURE)

미주호, FDA 리더십 변화에 유니큐어 투자의견 상향

Mizuho upgrades uniQure stock rating on FDA leadership change

Avago, Lumentum among market cap stock movers on Monday

유니큐어, FDA 수장 교체에 Chardan 목표 주가 상향